Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Active not recruiting 3Withdrawn 2Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Locally-advanced Rectal Cancer 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × ASTX-660 × Clear all
NCT05082259 2026-02-10

ASTEROID

Institute of Cancer Research, United Kingdom

Phase 1 Recruiting
61 enrolled
BreastGynecologic

Uterine Cervical Neoplasms, Triple Negative Breast Neoplasms

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting
78 enrolled
Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡